201 related articles for article (PubMed ID: 21205091)
21. Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription.
Subbaramaiah K; Benezra R; Hudis C; Dannenberg AJ
J Biol Chem; 2008 Dec; 283(49):33955-68. PubMed ID: 18842581
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells.
Sekiguchi F; Saito S; Takaoka K; Hayashi H; Nagataki M; Nagasawa K; Nishikawa H; Matsui H; Kawabata A
Biochem Pharmacol; 2007 Jan; 73(1):103-14. PubMed ID: 17069767
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
24. Role for cumulus cell-produced EGF-like ligands during primate oocyte maturation in vitro.
Nyholt de Prada JK; Lee YS; Latham KE; Chaffin CL; VandeVoort CA
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1049-58. PubMed ID: 19276391
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury.
Hsu D; Fukata M; Hernandez YG; Sotolongo JP; Goo T; Maki J; Hayes LA; Ungaro RC; Chen A; Breglio KJ; Xu R; Abreu MT
Lab Invest; 2010 Sep; 90(9):1295-305. PubMed ID: 20498653
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
27. Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor.
Shimada M; Hernandez-Gonzalez I; Gonzalez-Robayna I; Richards JS
Mol Endocrinol; 2006 Jun; 20(6):1352-65. PubMed ID: 16543407
[TBL] [Abstract][Full Text] [Related]
28. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.
Grabowska MM; Sandhu B; Day ML
Cell Signal; 2012 Feb; 24(2):532-538. PubMed ID: 22024284
[TBL] [Abstract][Full Text] [Related]
29. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
30. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
Doherty GA; Byrne SM; Molloy ES; Malhotra V; Austin SC; Kay EW; Murray FE; Fitzgerald DJ
BMC Cancer; 2009 Jun; 9():207. PubMed ID: 19558693
[TBL] [Abstract][Full Text] [Related]
31. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
32. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
[TBL] [Abstract][Full Text] [Related]
33. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
[TBL] [Abstract][Full Text] [Related]
34. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
35. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
36. Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.
Regales L; Gong Y; Shen R; de Stanchina E; Vivanco I; Goel A; Koutcher JA; Spassova M; Ouerfelli O; Mellinghoff IK; Zakowski MF; Politi KA; Pao W
J Clin Invest; 2009 Oct; 119(10):3000-10. PubMed ID: 19759520
[TBL] [Abstract][Full Text] [Related]
37. Novel role for amphiregulin in protection from liver injury.
Berasain C; García-Trevijano ER; Castillo J; Erroba E; Santamaría M; Lee DC; Prieto J; Avila MA
J Biol Chem; 2005 May; 280(19):19012-20. PubMed ID: 15753092
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor.
Takayama K; García-Cardena G; Sukhova GK; Comander J; Gimbrone MA; Libby P
J Biol Chem; 2002 Nov; 277(46):44147-54. PubMed ID: 12215436
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E₂-EP4 signaling suppresses adipocyte differentiation in mouse embryonic fibroblasts via an autocrine mechanism.
Inazumi T; Shirata N; Morimoto K; Takano H; Segi-Nishida E; Sugimoto Y
J Lipid Res; 2011 Aug; 52(8):1500-8. PubMed ID: 21646392
[TBL] [Abstract][Full Text] [Related]
40. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
